← Open Payments lookup

DAVID RYAN: Open Payments

NPI 1912918129 · KENNEWICK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,844 in 95 payments from 15 companies in 2025. Trend: 2023 $2,272 · 2024 $2,078 · 2025 $1,844

Food & beverage: $1,844
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$374
AstraZeneca Pharmaceuticals LP10$335
GlaxoSmithKline, LLC.15$247
PFIZER INC.15$224
Otsuka America Pharmaceutical, Inc.17$216
Vanda Pharmaceuticals Inc.3$100
Lilly USA, LLC5$94
ABBVIE INC.2$53
Boehringer Ingelheim Pharmaceuticals, Inc.2$44
Novo Nordisk Inc2$34

Products named: CAPLYTA, REXULTI, FARXIGA, TRELEGY ELLIPTA, ELIQUIS, SHINGRIX, NURTEC ODT, LOKELMA.

Industry payments across WA — which companies pay providers there.